Reports of Exempt Distribution

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Reports of Exempt Distribution

posted on Feb 04, 2023 09:01AM

--Dated: 2023-01-27

1 promissory Note CAN $500,000.00 out of Alberta

550K Common Share Purchase Warrants @ CAN $1.00 Expire 2028-01-27

--Dated: 2023-02-01

200K Common Share Purchase Warrants @ CAN $1.00 Expire 2028-02-01 out of Alberta

This could very well be Don McCaffrey (IMO)

Koo

1 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply